S. Sowa and K.M. Pietrusiewicz
Tetrahedron 86 (2021) 132057
solution in THF). After addition of BH3 complex the reaction
mixture was stirred at rt for 40 min. Reaction mixture was
quenched with addition of 5% NaHCO3 solution (5 mL). Then re-
action mixture was transferred to separation funnel and extracted
with CHCl3 (4 ꢂ 10 mL). The collected organic phases were dried
over Na2SO4, filtered off and evaporated to dryness. The residue
was purified by column chromatography using silica gel hexane/
AcOEt 6:1 as eluent.
procedure B to afford 5b (0.0355 g, 0.166 mmol, 83%) as a colourless
oil; Rf 0.53 (hexane/AcOEt 6:1). HRMS (ESI) found: 427.2076.
C
26H31B2P2 requires 2 Mþ, 427.2076). 1H NMR (500 MHz, CDCl3)
d
0.70e1.35 (bm, 3H), 1.88 (d, JH-P ¼ 10.09 Hz, 3H), 7.43e7.52 (m,
6H), 7.65e7.69 (m, 4H). 13C NMR (125 MHz, CDCl3)
d 11.8 (d, JP-
¼ 40.9 Hz, CH3), 128.8 (d, JP-C ¼ 10.0 Hz, CH), 130.4 (d, JP-
C
¼ 56.3 Hz, C), 131.1 (d, JP-C ¼ 1.8 Hz, CH), 131.7 (d, JP-C ¼ 10.0 Hz,
C
CH). 31P NMR (202 MHz, CDCl3)
d 9.75 (bm). These data are
1-Phenylphospholane-borane [26] (2a). (Table 1, entry 4). 1a
(0.072 g, 0.4 mmol) was reacted according to general procedure A
to afford 2a (0.0697 g, 0.392 mmol, 98%) as a colourless oil; Rf 0.70
consistent with those previously reported. [2g].
Diphenyl(methyl)phosphine [28] (4b). (Table 2, entry 4).
3b (0.0432 g, 0.2 mmol) was reacted with BH3-THF (0.8 mL,
0.8 mmol, 1 M solution in THF) according to modified general
procedure B to afford 4b (0.0228 g, 0.114 mmol, 57%) as a colourless
oil and 5b (0.0086 g, 0.04 mmol, 20%).
(hexane/AcOEt 2:1). 1H NMR (500 MHz, CDCl3)
d
0.50e1.20 (m, 3H),
2.00e2.29 (m, 8H), 7.46e7.53 (m, 3H), 7.72e7.75 (m, 2H). 13C NMR
(75 MHz, CDCl3)
26.7 (d, JP-C ¼ 37.1 Hz, CH2), 27.4 (s, CH2), 128.7 (d,
d
JP-C ¼ 9.8 Hz, CH), 130.9 (d, JP-C ¼ 2.3 Hz, CH), 131.3 (d, JP-C ¼ 46.6 Hz,
4b
C), 131.3 (d, JP-C ¼ 8.9 Hz, CH). 31P NMR (202 MHz, CDCl3)
d
28.60
Rf 0.85 (hexane/AcOEt 6:1). HRMS (ESI) found: 217.0779;
(bm). These data are consistent with those previously reported. [26].
C
13H13OP [M þ O þ H]þ requires: 217.0777. 1H NMR (500 MHz,
CDCl3)
d
1.65 (d, JH-P ¼ 3.47 Hz, 3H), 7.33e7.37 (m, 6H), 7.42e7.45
B. General Procedure for the reduction of tertiary phosphine ox-
(m, 4H). 13C NMR (125 MHz, CDCl3)
d
12.5 (d, JC-P ¼ 13.6 Hz, CH3),
ides 3 using Ti(Oi-Pr)4/BH3-THF (Table 2)
128.35 (d, JC-P ¼ 4.5 Hz, CH), 128.4 (d, JC-P ¼ 1.8 Hz, CH), 132.8 (d, JC-
¼ 18.7 Hz, CH), 140.1 (d, JC-P ¼ 11.8 Hz, C). 31P NMR (202 MHz,
P
In a Schlenk tube (25 mL) equipped with a magnetic stirrer and
an argon inlet, tertiary phosphine oxide 3 (0.2 mmol) in anhydrous
toluene (1 mL) was placed. Then, Ti(Oi-Pr)4 (0.177 mL, 0.6 mmol)
was added followed by BH3-THF complex (0.6 mL, 0.6 mmol, 1 M
solution in THF). After addition of BH3 the reaction mixture was
heated at 80 ꢀC for 24 h. Then, another portion of BH3-THF (0.6 mL,
0.6 mmol, 1 M solution in THF) was added and the mixture was left
at 80 ꢀC for 24 h to complete conversion of reaction and then re-
action was again checked using 31P NMR technique. Then, when
necessary another portion of BH3-THF (0.2 mL, 0.2 mmol, 1 M so-
lution in THF) was added to transform free phosphine to
phosphine-borane and reaction was left at rt until free phosphine
was consumed (3e10 h). After this time reaction was checked using
31P NMR technique. Then, the reaction mixture was quenched with
addition of 5% NaHCO3 solution (5 mL). Then reaction mixture was
transferred to separation funnel and extracted with CHCl3
(3 ꢂ 10 mL). The collected organic phases were dried over Na2SO4,
filtered off and evaporated to dryness. The residue was purified by
column chromatography using silica gel hexane/AcOEt 10:1 as
eluent.
CDCl3)
d
ꢁ26.82 (s). These data are consistent with those previously
o-Anisyl(methyl)phenylphosphine-borane [29] (5c). (Table 2,
entry 7). 3c (0.0492 g, 0.2 mmol) was reacted according to general
procedure B to afford 5c (0.0216 g, 0.094 mmol, 47%) as a white
solid; Rf 0.40 (hexane/AcOEt 10:1). 1H NMR (500 MHz, CDCl3)
d
0.64e1.35 (m, 3H), 1.95 (d, JH-P ¼ 10.56 Hz, 3H), 3.70 (s, 3H),
6.88e6.90 (m, 1H), 7.06e7.09 (m, 1H), 7.38e7.42 (m, 3H), 7.49e7.51
(m, 1H), 7.61e7.65 (m, 2H), 7.86e7.91 (m, 1H). 13C NMR (125 MHz,
CDCl3)
d
161.3 (s, C), 135.6 (d, JP-C ¼ 14.5 Hz, CH), 133.7 (d, JP-
¼ 2.7 Hz, CH), 128.5 (d, JP-C ¼ 59.0 Hz, C), 131.0 (d, JP-C ¼ 10.0 Hz,
C
CH), 130.3 (d, JP-C ¼ 2.7 Hz, CH), 128.3 (d, JP-C ¼ 10.9 Hz, CH),121.1 (d,
JP-C ¼ 11.8 Hz, CH), 117.3 (d, JP-C ¼ 54.5 Hz, C), 111.1 (d, JP-C ¼ 4.5 Hz,
CH), 51.3 (s, 3H), 10.5 (d, JP-C ¼ 42.7 Hz, C). 31P NMR (202 MHz,
CDCl3)
d
8.17 (bm). MS (70 eV): m/z (%): 230 (59) [M-BH3]þ, 229
(44), 213 (13), 212 (10), 199 (62), 197 (37), 183 (51), 170 (11). These
data are consistent with those previously reported. [29].
Diphenyl(phenylthiomethyl)phosphine-borane
(5d).
(Table 2, entry 8). 3d (0.0648 g, 0.2 mmol) was reacted according to
general procedure B to afford 5d (0.0419 g, 0.13 mmol, 65%) as a
white solid; Rf 0.46 (hexane/AcOEt 10:1); m.p. ¼ 75.5e76.5 ꢀC;
HRMS (ESI) found: 325.0818; C19H17OPS [M-BH3þO þ H]þ requires:
Triphenylphosphine [15b] (4a). (Table 2, entry 1). 3a (0.0556 g,
0.2 mmol) was reacted with BH3-THF (0.6 mL, 0.6 mmol, 1 M so-
lution in THF) according to modified general procedure B to afford
4a (0.0419 g, 0.16 mmol, 80%) as a white solid; Rf 0.81 (hexane/
325.0810. 1H NMR (500 MHz, CDCl3)
d 0.76e1.48 (m, 3H), 3.72 (d, JH-
¼ 7.25 Hz, 2H), 7.20e7.29 (m, 5H), 7.45e7.56 (m, 6H), 7.73e7.77
P
AcOEt 6:1). 1H NMR (500 MHz, CDCl3)
NMR (125 MHz, CDCl3)
¼ 4.5 Hz, CH), 128.4 (d, JP-C ¼ 1.8 Hz, CH), 128.6 (d, JP-C ¼ 1.8 Hz,
d
7.43e7.61 (m, 15H). 13C
(m, 4H). 13C NMR (125 MHz, CDCl3)
d
33.8 (d, JP-C ¼ 31.8 Hz, CH2),
d
123.2 (d, JP-C ¼ 7.2 Hz, CH), 123.6 (d, JP-
126.9 (s, CH), 127.8 (d, JP-C ¼ 55.4 Hz, C), 128.8 (d, JP-C ¼ 10.0 Hz, CH),
129.9 (s, CH), 131.6 (d, JP-C ¼ 2.7 Hz, CH), 132.6 (d, JP-C ¼ 9.1 Hz, CH),
C
CH). 31P NMR (202 MHz, CDCl3)
d
ꢁ5.36 (s). MS (70 eV): m/z (%): 263
135.8 (d, JP-C ¼ 4.5 Hz, C). 31P NMR (202 MHz, CDCl3)
d 18.99 (bm).
(10), 262 (67) [M]þ, 261 (20), 184 (20), 183 (100). These data are
consistent with those previously reported. [15b].
MS (70 eV): m/z (%): 308 (15) [M-BH3]þ, 307 (7), 263 (13), 262 (50),
217 (14), 199 (54), 197 (10).
Triphenylphosphine-borane [27] (5a). (Table 2, entry 2). 3a
(0.0556 g, 0.2 mmol) was reacted with BH3-THF (1.2 mL, 1.2 mmol,
1 M solution in THF) according to modified general procedure B to
afford 5a (0.0503 g, 0.182 mmol, 91%) as a white solid; Rf 0.62
Dimethyl(phenyl)phosphine-borane [2g] (5e). (Table 2, entry
9). 3e (0.05 g, 0.324 mmol) was reacted according to general pro-
cedure B to afford 5e (0.03 g, 0.198 mmol, 61%) as a colourless oil; Rf
0.55 (hexane/AcOEt 6:1). 1H NMR (500 MHz, CDCl3)
d
0.44e1.12
(bm, 3H), 1.58 (d, JH-P ¼ 10.40 Hz, 6H), 7.46e7.51 (m, 3H), 7.71e7.77
(m, 2H). 13C NMR (125 MHz, CDCl3)
(hexane/AcOEt 6:1). 1H NMR (500 MHz, CDCl3)
d
0.70e1.40 (bm,
3H), 7.43e7.61 (m, 15H). 13C NMR (125 MHz, CDCl3)
d
128.2 (d, JP-
d
12.9 (d, JP-C ¼ 39.1 Hz, CH3),
¼ 10.0 Hz, CH), 129.2 (d, JP-C ¼ 58.1 Hz, C), 131.2 (d, JP-C ¼ 2.7 Hz,
128.8 (d, JP-C ¼ 10.0 Hz, CH), 130.8 (d, JP-C ¼ 10.0 Hz, CH), 130.9 (d, JP-
C
CH), 133.2 (d, JP-C ¼ 10.0 Hz, CH). 31P NMR (202 MHz, CDCl3)
d
20.59
¼ 54.5 Hz, C), 131.2 (d, JP-C ¼ 1.8 Hz, CH). 31P NMR (202 MHz,
C
(bm). MS (70 eV): m/z (%): 263 (12), 262 (67) [M-BH3]þ, 261 (21),
184 (21), 183 (100). These data are consistent with those previously
CDCl3)
d
2.56 (bm). MS (70 eV): m/z (%): 151 (5) [M]þ, 150 (4), 149
(35), 148 (12), 139 (12), 138 (100) [M ꢁ BH3], 123 (39), 121 (37).
These data are consistent with those previously reported. [2g].
Diisopropyl(phenyl)phosphine-borane [30] (5f). (Table 2,
entry 10). 3f (0.042 g, 0.2 mmol) was reacted according to general
procedure B to afford 5f (0.0229 g, 0.144 mmol, 72%) as a white
Diphenyl(methyl)phosphine-borane [2g] (5b). (Table 2, entry
6).
3b (0.0432 g, 0.2 mmol) was reacted according to general
6